GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)
Generic Name: sofosbuvir/velpatasvir
Pill with imprint GSI 7916 is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is supplied by Gilead Sciences, Inc..
Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 7916
Epclusa
- Generic Name
- sofosbuvir/velpatasvir
- Imprint
- GSI 7916
- Strength
- sofosbuvir 400 mg / velpatasvir 100 mg
- Color
- Pink
- Size
- 20.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-2201
- Inactive Ingredients
-
alcohol,
copovidone,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
water,
titanium dioxide,
polyethylene glycol 3350,
magnesium silicate,
ferric oxide red
Note: Inactive ingredients may vary.
More about Epclusa (sofosbuvir / velpatasvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 267 Reviews
- Drug class: antiviral combinations
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.